๐ Encouraging news in ocular melanoma research!
Results from the OptimUM-09 trial show that darovasertib may help shrink tumors before treatment, allowing some patients to preserve their eyes and potentially their vision. In fact, 57% of evaluable patients facing eye removal were able to keep their eye! Read more about these promising findings and what comes next. ๐ https://acureinsight.org/neoadjuvant-darovasertib-helps-preserve-eyes-in-trial/ #OcularMelanoma #CancerResearch #HopeForACureSee it on Instagram โ